
Biodesix BDSX
$ 15.6
3.59%
Quarterly report 2026-Q1
added 05-23-2026
Biodesix Operating Cycle 2011-2026 | BDSX
Annual Operating Cycle Biodesix
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 36.4 | 41.7 | 47.4 | 41.6 | 63.5 | 61.3 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 63.5 | 36.4 | 48.6 |
Quarterly Operating Cycle Biodesix
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 42.2 | 34.4 | 41.3 | - | 45.7 | 51 | 54.1 | - | 33.5 | 34.7 | 50.2 | - | 18.3 | 15.7 | 51.8 | - | 56.3 | 90.8 | 53.2 | - | 152 | 329 | 184 | - | 61.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 329 | 15.7 | 73.7 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | ||
|
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | ||
|
Quest Diagnostics Incorporated
DGX
|
54.2 | $ 202.18 | -0.43 % | $ 22.4 B | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
1.79 K | $ 3.78 | -11.89 % | $ 5.03 M | ||
|
Fulgent Genetics
FLGT
|
87 | $ 18.35 | -1.77 % | $ 565 M | ||
|
Castle Biosciences
CSTL
|
97.4 | $ 20.66 | -0.19 % | $ 599 M | ||
|
Aspira Women's Health
AWH
|
1.2 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | ||
|
Guardant Health
GH
|
128 | $ 129.82 | -1.37 % | $ 16.3 B | ||
|
Interpace Biosciences
IDXG
|
96 | $ 1.58 | -1.56 % | $ 6.99 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 24.08 | 4.83 % | $ 1.28 B | ||
|
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | ||
|
Illumina
ILMN
|
204 | $ 166.89 | 3.68 % | $ 25.9 B | ||
|
ICON Public Limited Company
ICLR
|
63.4 | $ 147.72 | 1.05 % | $ 11.6 B | ||
|
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 154.47 | 2.03 % | $ 23.8 B | ||
|
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | ||
|
National Research Corporation
NRC
|
29.4 | $ 18.31 | -2.55 % | $ 410 M | ||
|
Natera
NTRA
|
48.3 | $ 216.97 | 2.31 % | $ 29.7 B | ||
|
Lantheus Holdings
LNTH
|
121 | $ 104.67 | 0.14 % | $ 7.06 B | ||
|
Charles River Laboratories International
CRL
|
65 | $ 188.47 | 0.51 % | $ 9.34 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | ||
|
Pacific Biosciences of California
PACB
|
244 | $ 1.32 | 0.76 % | $ 396 M | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 467.5 | 0.03 % | $ 13.5 B | ||
|
Exact Sciences Corporation
EXAS
|
91.7 | - | - | $ 19.8 B | ||
|
NeoGenomics
NEO
|
102 | $ 11.09 | -0.54 % | $ 1.42 B | ||
|
Myriad Genetics
MYGN
|
95.1 | $ 4.32 | -0.23 % | $ 400 M | ||
|
Personalis
PSNL
|
63.8 | $ 9.79 | 2.09 % | $ 874 M | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 26.69 | 0.87 % | $ 25.3 B | ||
|
Senseonics Holdings
SENS
|
104 | $ 7.24 | 0.84 % | $ 302 M | ||
|
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
1.04 K | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
204 | $ 2.0 | -2.44 % | $ 4.59 M | ||
|
Twist Bioscience Corporation
TWST
|
96.1 | $ 80.79 | 6.07 % | $ 4.83 B | ||
|
Laboratory Corporation of America Holdings
LH
|
71.8 | $ 265.03 | -0.42 % | $ 22.1 B | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 473.72 | 1.03 % | $ 179 B | ||
|
Trinity Biotech plc
TRIB
|
299 | $ 0.68 | 4.18 % | $ 244 M | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
213 | $ 9.3 | 2.2 % | $ 2.02 B | ||
|
Invitae Corporation
NVTA
|
368 | - | - | $ 21.2 M |